Pigment epithelial-derived factor expression in endometriotic lesions in a rat model of endometriosis
article
OA: closed
CC0
⤵ 12 in-corpus citations
AI-generated summary
This study investigated the expression of pigment epithelial-derived factor in endometriotic lesions within a rat model, analyzing its presence and potential role in the condition.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Angiogenesis is a prerequisite for endometriotic lesion formation and development. Pigment epithelium-derived factor (PEDF) is a potential inhibitor of angiogenesis. The objective of this study was to detect PEDF immunolocalization in endometriotic lesions and the correlation with vascular endothelial growth factor (VEGF) and microvascular density (MVD) in a rat model of endometriosis. A subcutaneous endometriosis rat model was established by using auto-transplantation. Expression of PEDF, VEGF and MVD labeled by von Willebrand factor (v-WF) in endometriotic lesions and endometrial tissues was evaluated using immunohistochemical staining. We detected lower PEDF immunostaining and higher VEGF and MVD immunostaining in active lesions in a rat model of endometriosis than that in endometriosis endometrium or control endometrium (P0.05). In lesions, PEDF expression was negatively correlated with VEGF expression, MVD or sizes of cysts (P<0.01). On the contrary, both VEGF expression and MVD were positively correlated with lesion sizes (P<0.05). In addition, VEGF expression was positively correlated with MVD (P<0.01). Our results suggest that PEDF might be involved in the pathogenesis of endometriosis and may lead to novel treatment for this disease.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (39)
- Angiogenesis and antiangiogenic therapy in endometriosis via openalex
- Antiangiogenesis Therapy for Endometriosis via openalex
- Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises via openalex
- Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model via openalex
- Concentrations of Receptor for Advanced Glycation End Products, VEGF and CML in Plasma, Follicular Fluid, and Peritoneal Fluid in Women With and Without Endometriosis via openalex
- Cytokine profiles in serum and peritoneal fluid from infertile women with and without endometriosis via openalex
- Effect of dienogest administration on angiogenesis and hemodynamics in a rat endometrial autograft model via openalex
- Effect of Vascular Endothelial Growth Factor Inhibition on Endometrial Implant Development in a Murine Model of Endometriosis via openalex
- Endostatin inhibits the growth of endometriotic lesions but does not affect fertility via openalex
- Enhanced expressions of matrix metalloproteinase (MMP)-2 and –9 and vascular endothelial growth factors (VEGF) and increased microvascular density in the endometrial hyperplasia of women with anovulatory dysfunctional uterine bleeding via openalex
- Higher expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) and metalloproteinase-9 (MMP-9) in a rat model of peritoneal endometriosis is similar to cancer diseases via openalex
- Increased Immunoreactivity to SLIT/ROBO1 in Ovarian Endometriomas via openalex
- Influence of peritoneal fluid on the expression of angiogenic and proteolytic factors in cultures of endometrial cells from women with endometriosis via openalex
- Metalloproteinases, vascular endothelial growth factor, and angiopoietin 1 and 2 in eutopic and ectopic endometrium via openalex
- Reduced Levels of Serum Pigment Epithelium-Derived Factor in Women With Endometriosis via openalex
- W1986991414 via openalex
- W2030544273 via openalex
- W2048767933 via openalex
- W2049019160 via openalex
- W2050110429 via openalex
- W2050124446 via openalex
- W2057941174 via openalex
- W1985959551 via openalex
- W2103357989 via openalex
- W2105089025 via openalex
- W2107597801 via openalex
- W2132273085 via openalex
- W2134168653 via openalex
- W1980866524 via openalex
- W1973266232 via openalex
- W2146493861 via openalex
- W1964110651 via openalex
- W1994297182 via openalex
- W1527288895 via openalex
- W1997410071 via openalex
- W2002268391 via openalex
- W2003937710 via openalex
- W1987077057 via openalex
- W2018304270 via openalex
Cited by (13)
- Noninvasive diagnosis of external genital endometriosis based on the determination of cytokines controlling angiogenesis 2026
- Additional file 1 of PCGEM1 promotes cell proliferation and migration in endometriosis by targeting miR-124-3p-mediated ANTXR2 expression 2023
- Polycondensed Peptide-Based Polymers for Targeted Delivery of Anti-Angiogenic siRNA to Treat Endometriosis 2023
- iRGD-Targeted Peptide Nanoparticles for Anti-Angiogenic RNAi-Based Therapy of Endometriosis 2023
- Additional file 1 of PCGEM1 promotes cell proliferation and migration in endometriosis by targeting miR-124-3p-mediated ANTXR2 expression 2023
- Biomarkers of endometriosis: How far have we come and where are we going? 2021
- Anti-angiogenic treatment of endometriosis via anti-VEGFA siRNA delivery by means of peptide-based carrier in a rat subcutaneous model 2018
- Basic mechanisms of vascularization in endometriosis and their clinical implications 2018
- miR-200c suppresses endometriosis by targeting MALAT1 in vitro and in vivo 2017
- Endocannabinoids modulate apoptosis in endometriosis and adenomyosis 2017
- MODELS, BIOLOGICAL Development of a subcutaneous endometriosis rat model 1 2015
- Development of a subcutaneous endometriosis rat model 2015
- A physiological approach for treating endometriosis by recombinant pigment epithelium-derived factor (PEDF) 2013
Source provenance
- europepmc
- last seen: 2026-08-02T06:10:09.037253+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:16:04.919516+00:00
License: CC0
· commercial use OK